Expression of B7 co-stimulatory molecules by B16 melanoma results in a natural killer cell-dependent local anti-tumour response, but induces T-cell-dependent systemic immunity only against B7-expressing tumours
1998

B7 Co-Stimulatory Molecules and Immune Response in Melanoma

Sample size: 10 publication Evidence: moderate

Author Information

Author(s): H Chong, G Hutchinson, IR Hart, RG Vile

Primary Institution: United Medical and Dental Schools of Guy's and St. Thomas's Hospitals

Hypothesis

Does the expression of B7 co-stimulatory molecules on B16 melanoma cells enhance the anti-tumor immune response?

Conclusion

B7-expressing tumors grow more slowly and induce a local anti-tumor response mediated by natural killer cells, but systemic immunity is dependent on T cells.

Supporting Evidence

  • B7-expressing tumors grew more slowly in immunocompetent mice.
  • The delay in tumor growth was dependent on natural killer cells.
  • Vaccination with irradiated B7-1 cells provided partial protection against live B7-1 cells.

Takeaway

When certain proteins are added to melanoma cells, the immune system can fight the cancer better, especially with the help of special immune cells called natural killer cells.

Methodology

B16 melanoma cells were modified to express B7-1 or B7-2, and their growth was monitored in different mouse models to assess immune response.

Limitations

The study primarily focused on specific mouse models, which may not fully represent human responses.

Participant Demographics

C57BL/6 mice and BALB/c nude mice were used in the experiments.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication